Pharmaceutical

Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company…

9 months ago

Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors

Dorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the…

9 months ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

CHARLOTTESVILLE, Va., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage…

9 months ago

SomaLogic expands agreement with Novo Nordisk to 2025

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseasesBOULDER, Colo., Sept.…

9 months ago

Medexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facility

Medexus expects net proceeds, together with projected cash on hand, to fully satisfy convertible debentures in cash at maturity in…

9 months ago

Satellos Expands Leadership Team with New CFO Appointment

Elizabeth Williams, CPA, CA, joins as CFO, bringing extensive expertise leading corporate finance and strategy for public biotech companies listed…

9 months ago

Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference

San Diego, California--(Newsfile Corp. - September 5, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing proprietary…

9 months ago

Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

9 months ago

Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress

New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life (QoL) when compared to baseline…

9 months ago

AQ Pharmaceuticals, Inc. Announces Results of JBA Brands GlucoTrojan (R) Study: Findings Show Reduction in Sugar Absorption

GARDEN GROVE, CA / ACCESSWIRE / September 3, 2023 / Affordable Quality Pharmaceuticals (AQP), established in 2000, has developed a…

9 months ago